company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2015000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2015000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,255000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,150000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,474000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4349000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5485000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5485000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-230000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-9000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6079000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10445000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4127000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4127000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-105000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,20000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-85000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-85000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1443000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,14000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2247000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2247000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,225000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,124000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,113000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3343000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5128000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5128000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-354000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-22000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4612000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11111000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6123000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6123000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-107000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,33000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-74000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-74000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,921000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,12000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 18:59:37+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,206000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2600000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2600000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,256000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,109000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,205000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2639000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4669000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4669000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-380000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-108000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2463000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2670000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-281000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-281000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-109000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-110000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-218000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-218000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5168000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q2,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,10000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5685000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5685000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,260000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,78000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2483000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3089000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,225000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,225000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,10000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-55000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2212000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10769000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8512000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8512000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-110000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1197000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5000000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,68000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3761000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3761000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12498000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,10000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q3,2012-07-01,2012-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6876000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6876000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,276000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,83000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3492000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3876000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,851000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,851000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-427000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-90000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-52754000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8533000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-44738000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-44738000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-119000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,1307000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,65686000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,139000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,67013000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,67013000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,23126000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-24000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7229000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7229000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,289000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,324000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2548000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3087000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7155000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7155000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-77000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-27000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18074000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2430000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15748000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15748000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-28000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,85000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,116000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,173000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,173000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 18:55:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22730000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7348000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7348000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,340000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,323000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3457000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4204000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7432000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7432000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-191000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-69000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1910000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10890000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8720000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8720000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-28000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,204000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-116000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,60000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,60000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1348000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q2,2013-04-01,2013-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2164000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2164000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,367000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,365000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,306000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3303000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4429000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4429000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-340000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,50000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-30406000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3200000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27496000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27496000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,56000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,84000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,46273000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,46245000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,46245000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14320000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12741000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12741000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,354000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,442000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3542000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-626000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9029000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9029000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-75000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-39780000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,29372000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10483000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10483000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-34000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9728000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,487000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10181000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10181000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9331000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,11000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:07:27+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11973000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11973000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,346000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,434000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,730000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,441000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10022000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10022000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-656000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-34000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8521000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20748000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11537000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11537000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-36000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,69000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,33000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,33000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1548000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,10000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9798000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9798000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,398000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,359000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-158000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,397000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8802000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8802000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-389000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-19000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3967000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12954000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8579000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8579000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-36000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,125000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,68000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,157000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,157000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-66000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,9000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22168000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22168000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,392000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,362000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15025000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5286000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11675000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11657000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-12000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-61149000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22347000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-38840000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-38840000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,106000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,142000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,76293000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1576000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,78117000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,77866000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,27369000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,9000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14487000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14487000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,394000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,425000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4964000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2548000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11252000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11252000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-236000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-37157000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30010000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7390000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7390000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-37000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,257000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,695000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,915000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,915000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17727000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,8000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 18:10:08+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21035000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21035000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,404000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,376000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5819000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4673000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9763000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9763000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-174000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-12000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9124000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19635000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10325000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10325000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-38000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,960000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,922000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,922000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1484000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,7000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13000000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13000000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,379000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,329000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2635000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2143000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11800000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11800000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-463000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-21000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-20783000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,26766000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5499000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5499000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-40000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,235000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3346000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3541000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3541000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2760000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,7000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7226000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7226000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,414000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,342000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3761000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14335000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17044000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17044000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-490000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-27000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11337000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24895000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13041000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13041000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1639000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2364000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,5000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21207000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21207000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,419000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,198000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3749000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7911000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8930000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8930000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-395000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-11000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-20475000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,32572000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11691000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11691000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-41000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,363000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,206000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,528000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,528000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3289000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,5000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 20:36:18+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21089000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21089000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,509000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,161000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2237000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,837000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17345000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17345000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,129000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-23000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9756000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14950000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5300000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5300000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-42000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,19819000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,59000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,19836000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,19836000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7791000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,49000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19520000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19520000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,661000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,166000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3467000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-274000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15500000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15500000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-480000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-14000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-30485000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,33915000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2936000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2936000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-41000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-51000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,278000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,44000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,230000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,230000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12334000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,464000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20020000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20020000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,687000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,141000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2225000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1860000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15107000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15107000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-167000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-5000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4394000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19950000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15384000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15384000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-43000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-42000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-42000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,235000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,463000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20021000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20021000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,699000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,107000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2381000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1846000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18680000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18680000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-139000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-16000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2265000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20780000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18360000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18360000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,265000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,268000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,268000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-52000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,465000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:17:44+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21608000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21608000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,658000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,74000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2830000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,719000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17327000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17327000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,15000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2188000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17149000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14976000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14976000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2351000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,481000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15828000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15828000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,585000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,90000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1266000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2222000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11665000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11665000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-93000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-44086000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20381000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-23798000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-23798000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,43146000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,43147000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,43147000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7684000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,498000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14448000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14448000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,582000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,78000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1093000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1594000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11101000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11101000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-86000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7147000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11631000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4398000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4398000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6703000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,500000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16025000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16025000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,563000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,47000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1609000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1796000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15602000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15602000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11439000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11439000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11439000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,208000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,493000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,701000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,701000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3462000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,506000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:23:09+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13848000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13848000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,558000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,40000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1339000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-298000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12209000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12209000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15712000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15712000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15712000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-75000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-75000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-75000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3428000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,539000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10273000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10273000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,551000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1372000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3100000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11445000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11445000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,22000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12950000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12972000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12928000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-833000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-62000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-884000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-884000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,599000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,528000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8563000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8563000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,590000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,56000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3549000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,351000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4017000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4017000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6440000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6440000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6440000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2509000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-63000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2572000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2572000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-149000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,500000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 16:36:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3260000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 16:36:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3260000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 16:36:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,502000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 16:36:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-242000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 16:36:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1433000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 16:36:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4433000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 16:36:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4433000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 16:36:57+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,161000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 16:36:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,161000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 16:36:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,161000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 16:36:57+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1364000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 16:36:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2086000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 16:36:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-65000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 16:36:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,657000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 16:36:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,657000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 16:36:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3615000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 16:36:57+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,437000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5016000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5016000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,171000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,823000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1669000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5691000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5691000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,282000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-161000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,113000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,113000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-613000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,15505000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-63000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14829000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14829000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9251000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,417000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5423000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5423000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,127000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,520000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,56000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4720000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4720000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-162000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-282000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,318000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-141000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-141000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-65000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-64000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-64000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4925000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,409000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4893000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4893000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,131000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,454000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-669000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4977000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4977000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-59000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,318000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-318000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-59000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-59000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,24578000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-67000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,24511000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,24511000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19475000.0
Regulus Therapeutics Inc,RGLS,,0001505512,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,392000.0
